Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2RL1 | P55085 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20610767 | 0.87 | F2RL1 (0.68) | F2RL1KMT2AATMFFAR1POLB | |
| SCHEMBL20221725 | 0.86 | F2RL1 (0.54) | F2RL1KMT2AMAPTLMNAL3MBTL1 | |
| SCHEMBL27622137 | 0.79 | P2RY10 (0.54) | F2RL1MAPTLMNAL3MBTL1POLB | |
| SCHEMBL31329309 | 0.78 | DGKA (0.54) | ALOX5NAAA | |
| SCHEMBL8867697 | 0.78 | ALOX5 (0.54) | F2RL1KMT2AMAPTLMNAL3MBTL1 | |
| SCHEMBL20610758 | 0.78 | F2RL1 (0.62) | F2RL1MAPTLMNAL3MBTL1FFAR1 | |
| SCHEMBL10687182 | 0.77 | FFAR1 (0.50) | F2RL1KMT2AMAPTL3MBTL1FFAR1 | |
| SCHEMBL9664592 | 0.77 | F2RL1 (0.66) | F2RL1FFAR1POLBALDH1A1ALOX5 | |
| SCHEMBL8585437 | 0.77 | F2RL1 (0.66) | F2RL1POLBALOX5CYP1A2CYP3A4 | |
| SCHEMBL7329940 | 0.77 | F2RL1 (0.85) | F2RL1FFAR1POLBALDH1A1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180155361-A1 | PALLADIUM-MEDIATED KETOLIZATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2018-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180155361-A1 | PALLADIUM-MEDIATED KETOLIZATION | ERLIN1, ERLIN2, PDK1 | F2RL1 3667/4885KMT2A 1493/4885ATM 3811/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.